(-)-Talarozole
98%
- Product Code: 106690
CAS:
201410-67-5
| Molecular Weight: | 377.51 g./mol | Molecular Formula: | C₂₁H₂₃N₅S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
(-)-Talarozole is primarily used in the treatment of skin disorders, particularly those related to excessive keratinization. It is an inhibitor of retinoic acid metabolism, which helps to regulate cell differentiation and proliferation in the skin.
One of its key applications is in the management of acne vulgaris, where it helps to reduce the severity of lesions by normalizing skin cell turnover and decreasing sebum production. It is also being explored for its potential in treating other dermatological conditions such as psoriasis and ichthyosis, where abnormal skin cell growth and shedding are problematic.
Additionally, (-)-Talarozole has shown promise in the treatment of certain types of cancer, particularly those that are sensitive to retinoic acid modulation. By inhibiting the breakdown of retinoic acid, it enhances the therapeutic effects of retinoids in cancer therapy, particularly in acute promyelocytic leukemia (APL) and other malignancies.
Its ability to modulate retinoic acid levels also makes it a candidate for research in other areas, such as neurodegenerative diseases and autoimmune disorders, where retinoic acid signaling plays a crucial role.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿27,108.00 |
+
-
|
(-)-Talarozole
(-)-Talarozole is primarily used in the treatment of skin disorders, particularly those related to excessive keratinization. It is an inhibitor of retinoic acid metabolism, which helps to regulate cell differentiation and proliferation in the skin.
One of its key applications is in the management of acne vulgaris, where it helps to reduce the severity of lesions by normalizing skin cell turnover and decreasing sebum production. It is also being explored for its potential in treating other dermatological conditions such as psoriasis and ichthyosis, where abnormal skin cell growth and shedding are problematic.
Additionally, (-)-Talarozole has shown promise in the treatment of certain types of cancer, particularly those that are sensitive to retinoic acid modulation. By inhibiting the breakdown of retinoic acid, it enhances the therapeutic effects of retinoids in cancer therapy, particularly in acute promyelocytic leukemia (APL) and other malignancies.
Its ability to modulate retinoic acid levels also makes it a candidate for research in other areas, such as neurodegenerative diseases and autoimmune disorders, where retinoic acid signaling plays a crucial role.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :